Latest news and press releases about Solventum Corporation (SOLV): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments.
Price
| Price | $88.03 |
| Market Cap | $15.2B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 10.73 |
| Price / Book | 3.18 |
| EV / EBITDA | 7.74 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 28.96% |
| Return on Invested Capital | 15.85% |
| Return on Assets | 10.07% |
| Gross Margin | 54.69% |
| Operating Margin | 24.99% |
| Net Margin | 17.26% |
Related companies: ALGN · DOCS · EHC · ELAN · ENSG · ICLR · QGEN
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of SOLV: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks